Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome
- PMID: 30740147
- PMCID: PMC6360758
- DOI: 10.1186/s13098-019-0408-z
Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome
Abstract
Background: Metabolic syndrome is characterized by the clustering of different metabolic abnormalities. Total bilirubin and gamma-glutamyltransferase (GGT) levels have been reported to be associated with this condition. However, the extent to which the interaction between these parameters affects metabolic syndrome is unknown. Therefore, we examined the association of total bilirubin and GGT levels with metabolic syndrome, and investigated the combined effect of the two parameters.
Methods: In this retrospective cohort study, we analyzed 8992 middle-aged Japanese subjects (4586 men, 4406 women; mean age, 44.8 ± 9.3 years) without metabolic syndrome from a cohort of employees undergoing annual health examinations. They were divided into four groups according to median total bilirubin and GGT levels: both-low, GGT-high, total bilirubin-high, and both-high. The incident of metabolic syndrome was evaluated during a follow-up of 2.8 ± 1.2 years.
Results: The incident rate of metabolic syndrome during the follow-up was 4.6% in the both-low group, 12.1% in the GGT-high group, 2.7% in the total bilirubin-high group, and 10.6% in the both-high group. Total bilirubin and GGT have an interaction effect on the risk of incident metabolic syndrome (p = 0.0222). The both-low [hazard ratio (HR), 1.37; 95% confidence interval (CI) 1.002-1.89], GGT-high (HR, 1.88; 95% CI 1.42-2.52), and both-high (HR, 2.07; 95% CI 1.56-2.80) groups showed an increased adjusted HR for incident metabolic syndrome after adjusting for covariates compared with the total bilirubin-high group.
Conclusions: The simultaneous presence of high total bilirubin and low GGT levels may be associated with a lower incidence of metabolic syndrome.
Keywords: Bilirubin; Gamma-glutamyltransferase; Metabolic syndrome.
Figures
Similar articles
-
Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.Obesity (Silver Spring). 2012 Apr;20(4):842-8. doi: 10.1038/oby.2011.136. Epub 2011 Jun 2. Obesity (Silver Spring). 2012. PMID: 21633402
-
Increased γ-glutamyltransferase and decreased total bilirubin are associated with metabolic syndrome in Korean postmenopausal women.Clin Chem Lab Med. 2010 Nov;48(11):1623-8. doi: 10.1515/CCLM.2010.302. Epub 2010 Aug 13. Clin Chem Lab Med. 2010. PMID: 20704533
-
Combined Effect of Initial and Longitudinal Increases in γ-Glutamyltransferase on Incident Metabolic Syndrome: ARIRANG Study.Yonsei Med J. 2017 Jul;58(4):763-769. doi: 10.3349/ymj.2017.58.4.763. Yonsei Med J. 2017. PMID: 28540989 Free PMC article.
-
Association Between Gamma-Glutamyl Transferase, Total Bilirubin and Systemic Lupus Erythematosus in Chinese Women.Front Immunol. 2021 Jun 29;12:682400. doi: 10.3389/fimmu.2021.682400. eCollection 2021. Front Immunol. 2021. PMID: 34276670 Free PMC article.
-
γ-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure.J Card Fail. 2011 Jul;17(7):577-84. doi: 10.1016/j.cardfail.2011.02.012. Epub 2011 Apr 22. J Card Fail. 2011. PMID: 21703530
Cited by
-
Gut microbiome is associated with metabolic syndrome accompanied by elevated gamma-glutamyl transpeptidase in men.Front Cell Infect Microbiol. 2022 Jul 29;12:946757. doi: 10.3389/fcimb.2022.946757. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35967853 Free PMC article.
-
Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome.Metabolism. 2025 Feb;163:156081. doi: 10.1016/j.metabol.2024.156081. Epub 2024 Nov 22. Metabolism. 2025. PMID: 39580049 Review.
-
Age-Specific Association Between Body Mass Index and the Incidence of Atrial Fibrillation in Japanese Men.Circ Rep. 2020 Aug 13;2(9):466-470. doi: 10.1253/circrep.CR-20-0067. Circ Rep. 2020. PMID: 33693271 Free PMC article.
-
Cross-sectional association between gamma-glutamyl transferase and hyperuricaemia: the China Multi-Ethinic Cohort (CMEC) study.BMJ Open. 2022 May 30;12(5):e058793. doi: 10.1136/bmjopen-2021-058793. BMJ Open. 2022. PMID: 35636797 Free PMC article.
-
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment.Mol Pharm. 2021 Sep 6;18(9):3563-3577. doi: 10.1021/acs.molpharmaceut.1c00462. Epub 2021 Aug 24. Mol Pharm. 2021. PMID: 34428046 Free PMC article.
References
-
- Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156:1070–1077. doi: 10.1093/aje/kwf145. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous